&nbsp;

Aug 2023

Drug

aldesleukin

Other Name(s): Proleukin® (interleukin-2)

Quick Link(s):

Apr 2024

Drug

ipilimumab

Other Name(s): Yervoy®

Quick Link(s):

Aug 2024

Drug

arsenic trioxide

Other Name(s): Trisenox®

Quick Link(s):

Oct 2023

Regimen

ALDE(Intralesional)

Cancer Type:

Skin,

Melanoma

Intent: Palliative, Curative

Funding:

New Drug Funding Program

Aldesleukin (interleukin-2) - In-Transit Metastases from Melanoma

Drugs Used:

aldesleukin

Quick Link(s):

Regimen Monograph

May 2019

Regimen

AZCT

Cancer Type:

Hematologic,

Leukemia - Acute Myeloid (AML),

Myelodysplastic Syndrome (MDS),

Myeloproliferative Neoplasms (MPNs)

Intent: Palliative

Funding:

New Drug Funding Program

Azacitidine - Intermediate-2 and high-risk myelodysplastic syndrome (MDS)

New Drug Funding Program

Azacitidine - Acute Myeloid Leukemia (AML)

New Drug Funding Program

Azacitidine - Acute Myeloid Leukemia (AML) Greater Than 30% Blasts

Drugs Used:

azaCITIDine

Quick Link(s):

Regimen Monograph

Jul 2023

Regimen

IRIN+CETU; IRIN(Q2W)+CETU

Cancer Type:

Gastrointestinal,

Colorectal,

Small bowel and appendix

Intent: Palliative

Funding:

New Drug Funding Program

Cetuximab with Irinotecan - Metastatic Colorectal, Small Bowel, or Appendiceal Cancer

Drugs Used:

cetuximab,

irinotecan

Quick Link(s):

Regimen Monograph

Jun 2022

Regimen

AC-DOCE; AC-DOCE+TRAS

Cancer Type:

Breast

Intent: Neoadjuvant, Adjuvant

Funding:

New Drug Funding Program

Trastuzumab (Biosimilar) - Adjuvant Treatment for Breast Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Feb 2022

Regimen

AC-PACL(W); AC-PACL(W)+TRAS

Cancer Type:

Breast

Intent: Neoadjuvant, Adjuvant

Funding:

New Drug Funding Program

Trastuzumab (Biosimilar) - Adjuvant Treatment for Breast Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Feb 2022

Regimen

AC-PACL(DD); AC-PACL(DD)+TRAS

Cancer Type:

Breast

Intent: Neoadjuvant, Adjuvant

Funding:

New Drug Funding Program

Trastuzumab (Biosimilar) - Adjuvant Treatment for Breast Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph, Patient Info Sheet (AC-PACL(DD)), Patient Info Sheet (AC-PACL(DD)+TRAS)

Jan 2024

Regimen

AC-PACL; AC-PACL+TRAS

Cancer Type:

Breast

Intent: Neoadjuvant, Adjuvant

Funding:

New Drug Funding Program

Trastuzumab (Biosimilar) - Adjuvant Treatment for Breast Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Feb 2022

Regimen

IPIL

Cancer Type:

Skin,

Melanoma

Intent: Palliative

Funding:

New Drug Funding Program

Ipilimumab - Previously Untreated Advanced Unresectable Melanoma

New Drug Funding Program

Ipilimumab - Previously Treated Advanced Unresectable Melanoma

Drugs Used:

ipilimumab